MyAverix Finance
US · Healthcare
Artiva Biotherapeutics, Inc. Common Stock (ARTV)
Biotechnology
Artiva Biotherapeutics, Inc. Common Stock (ARTV) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for ARTV
Artiva Biotherapeutics, Inc. Common Stock (ARTV) — FAQ
What is ARTV's P/E ratio?
The price-to-earnings (P/E) ratio for Artiva Biotherapeutics, Inc. Common Stock (ARTV) is 25.00 (data as of 2026-05-23).
Does Artiva Biotherapeutics, Inc. Common Stock pay a dividend?
Dividend yield is not available in the current snapshot for Artiva Biotherapeutics, Inc. Common Stock (ARTV). Check the MyAverix Finance app for the latest dividend data.
What sector is Artiva Biotherapeutics, Inc. Common Stock in?
Artiva Biotherapeutics, Inc. Common Stock (ARTV) is classified in the Healthcare sector (Biotechnology industry).
What exchange is ARTV listed on?
ARTV is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.